Company Overview
Snapshot
Founded in August 2018 by Claudia M Barzilay, Nanomedic Technologies operates with 11–50 employees. The company has raised $13.01 million across 8 funding rounds from 3 investors. In March 2021, Nanomedic Technologies appointed Mark Darty as CEO and established its U.S. headquarters, signaling an acceleration of its global expansion strategy.
Business overview
Nanomedic Technologies is a biomedical therapeutics technology company focused on advanced wound treatment. The company develops and distributes its innovative EHF technology and SpinCare System platform, which utilizes electrospinning to biomimic the natural structure of human tissue. This technology creates a temporary skin substitute that promotes tissue integration and regeneration, aiming to expedite recovery and minimize complications. The portable SpinCare System also allows for the controlled release of therapeutic additives into wounds. Nanomedic, a spin-off from Nicast, serves the healthcare industry, particularly providers, with its medical devices and nanotechnology solutions.
Strategic signal
In September 2021, Nanomedic Technologies established its U.S. headquarters in Memphis, following the appointment of Mark Darty as CEO in March 2021. This move indicates a strategic focus on expanding its market presence and operations within North America, suggesting a significant push for commercialization and growth in a key healthcare market. For investors, this signals a company transitioning from development to aggressive market penetration, aiming to capitalize on its CE-certified SpinCare system.
Log in to access full profile ›Company Intelligence Q&A
- What is Nanomedic Technologies' core product?
- Nanomedic Technologies' core product is the SpinCare System, which utilizes EHF electrospinning technology to create a temporary skin substitute for advanced wound treatment. This system is designed to biomimic natural tissue structure and facilitate tissue regeneration.
- When did Nanomedic Technologies appoint its current CEO and establish its U.S. headquarters?
- In March 2021, Nanomedic Technologies appointed Mark Darty as CEO and opened its U.S. headquarters, indicating a strategic move towards accelerating global expansion.
- What was a significant strategic development for Nanomedic Technologies in the U.S. market?
- In September 2021, Nanomedic Technologies based its U.S. headquarters in Memphis, Tennessee, as part of its plans for expansion in the American market.
- Which investors participated in Nanomedic Technologies' funding rounds?
- Investors such as OurCrowd and Citrine Global have participated in funding rounds for Nanomedic Technologies.
- What is the primary application of Nanomedic Technologies' electrospinning technology?
- Nanomedic Technologies' electrospinning EHF technology is primarily used to create a temporary skin substitute that encourages quick and efficient tissue integration and regeneration to expedite recovery from wounds.